
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Feb 21, 2026 03:05 am UTC| Business Health Governance
Vanda Pharmaceuticals (NASDAQ: VNDA) has secured FDA approval for its new drug, BYSANTI (milsaperidone), marking a significant milestone for the biotech company. The treatment is approved for Bipolar I disorder manic...

Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Feb 17, 2026 13:21 pm UTC| Insights & Views Health
Intermittent fasting has become a buzzword in nutrition circles, with many people looking to it as a way to lose weight or improve their health. But new research from the Cochrane Collaboration shows intermittent fasting...

Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Feb 13, 2026 08:30 am UTC| Business Health
Novartis announced that its investigational drug Vanrafia has successfully demonstrated the ability to slow kidney function decline in adults living with IgA nephropathy (IgAN), a chronic and progressive autoimmune kidney...

Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Feb 12, 2026 02:31 am UTC| Business Health Governance
Novocure (NASDAQ: NVCR) stock soared more than 30% in extended trading Wednesday after the U.S. Food and Drug Administration (FDA) approved its Optune Pax device for the treatment of locally advanced pancreatic cancer. The...

FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Feb 11, 2026 01:46 am UTC| Governance Business Health
The U.S. Food and Drug Administration (FDA) has declined to review Modernas approval application for its experimental influenza vaccine, mRNA-1010, a decision that sent the companys shares down about 8% in extended...

Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Feb 11, 2026 01:30 am UTC| Business Health Governance
Moderna Inc. (NASDAQ: MRNA) shares declined sharply in after-hours trading on Tuesday after the biotechnology company disclosed that the U.S. Food and Drug Administration (FDA) has declined to review its influenza vaccine...

Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Feb 09, 2026 05:22 am UTC| Business Health
Innovent Biologics Inc (HK:1801) shares surged in Hong Kong trading on Monday after the Chinese biotech company announced a major new partnership with longtime U.S. collaborator Eli Lilly and Company (NYSE:LLY), focused on...